OB Holdings Receives Legal Notice For Infringing IP Rights
OB Holdings Receives Legal Notice For Infringing IP Rights
OB Holdings Berhad has informed that its subsidiary Orient Biotech Sdn Bhd had received a legal notice from Nature One Dairy (Hong Kong) Limited who is a customer of the group for breaching the purchase & supply agreement and that OB had infringed intellectual property rights of NOD.
The customer had subsequently invoked a Dispute Notice which states if any dispute or difference arises between the parties in respect of any matter relating to the NOD Agreement or a breach thereof, the party claiming that a Dispute has arisen must notify the other party in writing giving details of the Dispute.
Orient Biotech has been requested by NOD to provide a written confirmation that it will cease and desist from any dealings in respect of manufacture of a certain milk powder product for a particular new customer of the Group and provide full discovery of all dealings related to the product.
Based on the Dispute Notice, NOD is alleging that Orient Biotech is in breach of the agreement for infringement of NOD's intellectual property rights for manufacturing product using formulations, recipes and ingredients which are identical or very similar to its formulations, recipes and ingredients for the milk powder products manufactured by Orient Biotech for NOD.
OB says the contents of the Dispute Notice are inadequate to sufficiently determine the basis or merits of its claim.
Ob控股有限公司已通知其子公司东方证券生物科技私人有限公司收到了来自香港Nature One Dairy(香港)有限公司的法律通知,后者是该集团的客户,因违反购买和供应协议而Ob侵犯了NOD的知识产权。
客户随后发出了争议通知,其中指出如果双方在NOD协议或违反协议事项方面发生任何争议或分歧,声称存在争议的一方必须书面通知另一方,并提供有关争议的详细信息。
NOD已要求东方生物科技书面确认将停止并停止与集团的某一新客户有关的某种牛奶粉产品的一切交易,并提供与该产品相关的所有交易的完整披露。
根据争议通知,NOD声称东方生物科技侵犯了协议,违反了NOD知识产权,制造产品使用与其为NOD生产的牛奶粉产品的配方、配方和成分完全相同或非常相似的配方、配方和成分。
Ob表示争议通知内容不足以充分确定其索赔的依据或价值。